切换至 "中华医学电子期刊资源库"

中华神经创伤外科电子杂志 ›› 2023, Vol. 09 ›› Issue (02) : 112 -118. doi: 10.3877/cma.j.issn.2095-9141.2023.02.009

综述

创伤后应激障碍的治疗现状及研究进展
栾恒钰, 赛晓勇()   
  1. 100853 北京,解放军总医院研究生院统计学与流行病学教研室
  • 收稿日期:2022-09-07 出版日期:2023-04-15
  • 通信作者: 赛晓勇

Treatment status and research progress of post-traumatic stress disorder

Hengyu Luan, Xiaoyong Sai()   

  1. Department of Statistics and Epidemiology, Graduate School of PLA General Hospital, Beijing 100853, China
  • Received:2022-09-07 Published:2023-04-15
  • Corresponding author: Xiaoyong Sai
  • Supported by:
    Technical Field Fund of The Basic Strengthening Plan of The Military Science and Technology Commission(2021-JCJQ-JJ-0528); Study on the Clinical Characteristics of Beijing(Z181100001718007)
引用本文:

栾恒钰, 赛晓勇. 创伤后应激障碍的治疗现状及研究进展[J]. 中华神经创伤外科电子杂志, 2023, 09(02): 112-118.

Hengyu Luan, Xiaoyong Sai. Treatment status and research progress of post-traumatic stress disorder[J]. Chinese Journal of Neurotraumatic Surgery(Electronic Edition), 2023, 09(02): 112-118.

创伤后应激障碍(PTSD)是个体在遇到突发性、灾难性或威胁性事件后而产生的一种精神障碍,治疗方式主要包括心理干预、药物治疗、物理疗法、中医特色疗法以及营养干预疗法,但疗效不一。由于PTSD发病机制的复杂性、症状的多样性、患者个体的差异性,不同类型的PTSD患者目前尚无统一、标准化的临床路径。本文通过参阅相关国际临床实践指南,汇总国内外最新研究进展,对PTSD的治疗现状进行梳理和汇总,以期为进一步探索PTSD的发病机制和精准高效的治疗方法提供参考依据。

Post-traumatic stress disorder (PTSD) is a mental disorder that occurs in individuals after encountering sudden, catastrophic, or threatening events. The treatment methods mainly include psychological intervention, drug therapy, physical therapy, traditional Chinese medicine characteristic therapy, and nutritional intervention therapy, and the effects varies. Due to the complexity of PTSD pathogenesis, diversity of symptoms, and individual differences in patients, there is currently no unified and standardized clinical pathway for different types of PTSD patients. In this article, the latest research progress at home and abroad is summarized by referring to relevant international clinical practice guidelines, and the current treatment status of PTSD is sorted out and summarized, in order to provide a reference for further exploring the pathogenesis and precise and efficient treatment methods of PTSD.

[1]
Ressler KJ, Berretta S, Bolshakov VY, et al. Post-traumatic stress disorder: clinical and translational neuroscience from cells to circuits[J]. Nat Rev Neurol, 2022, 18(5): 273-288. DOI: 10.1038/S41582-022-00635-8.
[2]
Berger W, Coutinho ESF, Figueira I, et al. Rescuers at risk: a systematic review and meta-regression analysis of the worldwide current prevalence and correlates of PTSD in rescue workers[J]. Soc Psychiatry Psychiatr Epidemiol, 2012, 47(6): 1001-1011. DOI: 10.1007/s00127-011-0408-2.
[3]
王焕林,崔庶,陈继军,等.中国军人心理创伤后应激障碍的流行学调查[J].中华精神科杂志, 1996, 29(2): 69-72. DOI: 10.1007/BF02951625.
[4]
Ben-Ezra M. Trauma 4,000 years ago?[J]. Am J Psychiatry, 2002, 159(8): 1437. DOI: 10.1176/appi.ajp.159.8.1437.
[5]
Kucmin T, Kucmin A, Nogalski A, et al. History of trauma and posttraumatic disorders in literature[J]. Psychiatr Pol, 2016, 50(1): 269-281. DOI: 10.12740/PP/43039.
[6]
Regier DA, Kuhl EA, Kupfer DJ. The DSM-5: classification and criteria changes[J]. World Psychiatry, 2013, 12(2): 92-98. DOI: 10.1002/wps.20050.
[7]
Brewin CR, Cloitre M, Hyland P, et al. A review of current evidence regarding the ICD-11 proposals for diagnosing PTSD and complex PTSD[J]. Clin Psychol Rev, 2017, 58: 1-15. DOI: 10.1016/j.cpr.2017.09.001.
[8]
Murphy D, Karatzias T, Busuttil W, et al. ICD-11 posttraumatic stress disorder (PTSD) and complex PTSD (CPTSD) in treatment seeking veterans: risk factors and comorbidity[J]. Soc Psychiatry Psychiatr Epidemiol, 2021, 56(7): 1289-1298. DOI: 10.1007/S00127-021-02028-6.
[9]
范艳竹,刘伟明,徐珑,等.创伤性脑损伤患者创伤后成长与创伤后应激障碍的调查研究[J].中华神经创伤外科电子杂志, 2020, 6(6): 338-343. DOI: 10.3877/cma.j.issn.2095-9141.2020.06.004.
[10]
Guideline Development Panel for the Treatment of PTSD in Adults, American Psychological Association. Summary of the clinical practice guideline for the treatment of posttraumatic stress disorder (PTSD) in adults[J]. Am Psychol, 2019, 74(5): 596-607. DOI: 10.1037/amp0000473.
[11]
Resick PA, Nishith P, Weaver TL, et al. A comparison of cognitive-processing therapy with prolonged exposure and a waiting condition for the treatment of chronic posttraumatic stress disorder in female rape victims[J]. J Consult Clin Psychol, 2002, 70(4): 867-879. DOI: 10.1037//0022-006x.70.4.867.
[12]
König J, Kopp B, Ziegelmeier A, et al. Young people's trauma-related cognitions before and after cognitive processing therapy for post-traumatic stress disorder[J]. Psychol Psychother, 2021, 94(1): 33-44. DOI: 10.1111/papt.12263.
[13]
Roberge EM, Weinstein HR, Bryan CJ. Predicting response to cognitive processing therapy: does trauma history matter?[J]. Psychol Trauma, 2022, 14(5): 871-882. DOI: 10.1037/tra0000530.
[14]
Rosner R, Rimane E, Frick U, et al. Effect of developmentally adapted cognitive processing therapy for youth with symptoms of posttraumatic stress disorder after childhood sexual and physical abuse: a randomized clinical trial[J]. JAMA Psychiatry, 2019, 76(5): 484-491. DOI: 10.1001/jamapsychiatry.2018.4349.
[15]
Harvey AG, Bryant RA, Tarrier N. Cognitive behaviour therapy for posttraumatic stress disorder[J]. Clin Psychol Rev, 2003, 23(3): 501-22. DOI: 10.1016/s0272-7358(03)00035-7.
[16]
Smith P, Yule W, Perrin S, et al. Cognitive-behavioral therapy for PTSD in children and adolescents: a preliminary randomized controlled trial[J]. J Am Acad Child Adolesc Psychiatry, 2007, 46(8): 1051-1061. DOI: 10.1097/CHI.0b013e318067e288.
[17]
Delrue N. Cognitive treatment of post-traumatic stress disorder in the elderly. A longitudinal study[J]. Encephale, 2021, 47(1): 64-71. DOI: 10.1016/j.encep.2020.05.016
[18]
Shapiro F. Eye movement desensitization: a new treatment for post-traumatic stress disorder[J]. J Behav Ther Exp Psychiatry, 1989, 20(3): 211-217. DOI: 10.1016/0005-7916(89)90025-6.
[19]
Fernandez I, Giovannozzi G. EMDR and adaptive information processing. Psychotherapy as a stimulation of the self-reparative psychological processes[J]. Riv Psichiatr, 2012, 47(2 Suppl): 4-7. DOI: 10.1708/1071.11731.
[20]
Karadag M, Gokcen C, Sarp AS. EMDR therapy in children and adolescents who have post-traumatic stress disorder: a six-week follow-up study[J]. Int J Psychiatry Clin Pract, 2020, 24(1): 77-82. DOI: 10.1080/13651501.2019.1682171.
[21]
Zepeda Méndez M, Nijdam MJ, Ter Heide FJJ, et al. A five-day inpatient EMDR treatment programme for PTSD: pilot study[J]. Eur J Psychotraumatol, 2018, 9(1): 1425575. DOI: 10.1080/20008198.2018.1425575.
[22]
Diehle J, Opmeer BC, Boer F, et al. Trauma-focused cognitive behavioral therapy or eye movement desensitization and reprocessing: what works in children with posttraumatic stress symptoms? A randomized controlled trial[J]. Eur Child Adolesc Psychiatry, 2015, 24(2): 227-236. DOI: 10.1007/s00787-014-0572-5.
[23]
Jaberghaderi N, Rezaei M, Kolivand M, et al. Effectiveness of cognitive behavioral therapy and eye movement desensitization and reprocessing in child victims of domestic violence[J]. Iran J Psychiatry, 2019, 14(1): 67-75. DOI: 10.18502/ijps.v14i1.425.
[24]
王新燕,张桂青,胡敏,等.眼动脱敏和再加工与认知行为疗法对创伤后应激障碍患者生活质量的效果比较[J].中国健康心理学杂志, 2017, 25(7): 969-973. DOI: 10.13342/j.cnki.cjhp.2017.07.003.
[25]
Foa EB, Kozak MJ. Emotional processing of fear: exposure to corrective information[J]. Psychol Bull, 1986, 99(1): 20-35. DOI: 10.1037/0033-2909.99.1.20.
[26]
Eftekhari A, Ruzek JI, Crowley JJ, et al. Effectiveness of national implementation of prolonged exposure therapy in veterans affairs care[J]. JAMA Psychiatry, 2013, 70(9): 949-955. DOI: 10.1001/jamapsychiatry.2013.36.
[27]
Bryant RA, Mastrodomenico J, Felmingham KL, et al. Treatment of acute stress disorder: a randomized controlled trial[J]. Arch Gen Psychiatry, 2008, 65(6): 659-667. DOI: 10.1001/archpsyc.65.6.659.
[28]
周瑶光,孙露娜,刘伟志.创伤后应激障碍的心理治疗:近5年RCT回顾[J].解放军医学杂志, 2019, 44(9): 797-807. DOI: 10.11855/j.issn.0577-7402.2019.09.16.
[29]
徐书琦,万瑾凌,王学义,等.虚拟现实暴露疗法治疗创伤后应激障碍的meta分析[J].中国心理卫生杂志, 2021, 35(9): 745-750. DOI: 10.3969/j.issn.1000-6729.2021.09.008.
[30]
王日出,赛晓勇.汶川地震受灾人群中的灾难心理学研究进展[J].中华医学杂志, 2016, 96(37): 3032-3035. DOI: 10.3760/cma.j.issn.0376-2491.2016.37.018
[31]
Marshall RD, Beebe KL, Oldham M, et al. Efficacy and safety of paroxetine treatment for chronic PTSD: a fixed-dose, placebo-controlled study[J]. Am J Psychiatry, 2001, 158(12): 1982-1988. DOI: 10.1176/appi.ajp.158.12.1982.
[32]
Li W, Ma YB, Yang Q, et al. Effect and safety of sertraline for treat posttraumatic stress disorder: a multicenter randomised controlled study[J]. Int J Psychiatry Clin Pract, 2017, 21(2): 151-155. DOI: 10.1080/13651501.2017.1291838.
[33]
Brunet A, Saumier D, Liu A, et al. Reduction of PTSD symptoms with pre-reactivation rropranolol therapy: a randomized controlled trial[J]. Am J Psychiatry, 2018, 175(5): 427-433. DOI: 10.1176/appi.ajp.2017.17050481.
[34]
Raskind MA, Peskind ER, Kanter ED, et al. Reduction of nightmares and other PTSD symptoms in combat veterans by prazosin: a placebo-controlled study[J]. Am J Psychiatry, 2003, 160(2): 371-373. DOI: 10.1176/appi.ajp.160.2.371.
[35]
Raskind MA, Peskind ER, Chow B, et al. Trial of prazosin for post-traumatic stress disorder in military veterans[J]. N Engl J Med, 2018, 378(6): 507-517. DOI: 10.1056/NEJMoa1507598.
[36]
Jakovljević M, Sagud M, Mihaljević-Peles A. Olanzapine in the treatment-resistant, combat-related PTSD--a series of case reports[J]. Acta Psychiatr Scand, 2003, 107(5): 394-396; discussion 396. DOI: 10.1034/j.1600-0447.2003.00065.x.
[37]
Bastien DL. Pharmacological treatment of combat-induced PTSD: a literature review[J]. Br J Nurs, 2010, 19(5): 318-321. DOI: 10.12968/bjon.2010.19.5.47074.
[38]
Deka R, Bryan CJ, LaFleur J, et al. Benzodiazepines, health care utilization, and suicidal behavior in veterans with posttraumatic stress disorder[J]. J Clin Psychiatry, 2018, 79(6): 17m12038. DOI: 10.4088/JCP.17m12038.
[39]
Mitchell JM, Bogenschutz M, Lilienstein A, et al. MDMA-assisted therapy for severe PTSD: a randomized, double-blind, placebo-controlled phase 3 study[J]. Nat Med, 2021, 27(6): 1025-1033. DOI: 10.1038/S41591-021-01336-3.
[40]
杨雪艳,何玉梅,肖夏,等.论惊和恐在创伤后应激障碍中的作用[J].中国民族民间医药, 2016, 25(5): 52-53. DOI: 10.3969/j.issn.1007-8517.2016.5.zgmzmjyyzz201605027.
[41]
彭晓明,唐珂,高丽波,等.金匮肾气丸治疗创伤后应激障碍的临床疗效观察[J].西部中医药, 2021, 34(6): 95-98. DOI: 10.12174/j.issn.2096-9600.2021.06.23.
[42]
李越峰,张育贵,牛江涛,等.中医药防治新型冠状病毒肺炎所致创伤后应激障碍用药探析[J].中草药, 2020, 51(5): 1130-1138. DOI: 10.7501/j.issn.0253-2670.2020.05.006.
[43]
李晓艳,孙一萍,卢峻,等.针灸治疗创伤后应激障碍近5年研究进展[J].针刺研究, 2021, 46(5): 439-444. DOI: 10.13702/j.1000-0607.200654.
[44]
Hollifield M, Sinclair-Lian N, Warner TD, et al. Acupuncture for posttraumatic stress disorder: a randomized controlled pilot trial[J]. J Nerv Ment Dis, 2007, 195(6): 504-513. DOI: 10.1097/NMD.0b013e31803044f8.
[45]
侯良芹,刘嵩,熊克仁.电针对创伤后应激障碍模型大鼠海马神经元型一氧化氮合酶表达的影响[J].中国针灸, 2013, 33(7): 632-636.
[46]
韩雅迪. "疏肝调神"针法对PTSD模型大鼠神经行为学及认知功能障碍的干预研究[D].兰州:甘肃中医药大学, 2017.
[47]
王彧,胡幼平.针灸治疗地震创伤后应激障碍69例[J].河南中医, 2009, 29(3): 291. DOI: 10.16367/j.issn.1003-5028.2009.03.010.
[48]
汪红梅,吕学玉,胡永东.中医在干预心理危机中的应用[J].中医药导报, 2011, 17(11): 76-78. DOI: 10.3969/j.issn.1672-951X.2011.11.033.
[49]
任岳波,王晴,杨小青,等.新型冠状病毒肺炎一线医护人员身心调节的中医非药物疗法[J].解放军预防医学杂志, 2020, 38(1): 111-113.
[50]
王艺,彭李,周贤丽,等. rTMS对创伤后康复期PTSD患者核心症状、正负性情绪和心理弹性的影响[J].第三军医大学学报, 2015, 37(15): 1571-1575. DOI: 10.16016/j.1000-5404.201412167.
[51]
宋歌,柳刚,蒋良,等.重复经颅磁刺激治疗创伤后应激障碍的Meta分析[J].中国组织工程研究, 2022, 26(32): 5196-5200.
[52]
Ahmadi N, Moss L, Hauser P, et al. Clinical outcome of maintenance electroconvulsive therapy in comorbid Posttraumatic Stress disorder and major depressive disorder[J]. J Psychiatr Res, 2018, 105: 132-136. DOI: 10.1016/j.jpsychires.2018.08.023.
[53]
Matsuoka Y, Nishi D, Yonemoto N, et al. Omega-3 fatty acids for secondary prevention of posttraumatic stress disorder after accidental injury: an open-label pilot study[J]. J Clin Psychopharmacol, 2010, 30(2): 217-219. DOI: 10.1097/JCP.0b013e3181d48830.
[54]
Matsuoka Y, Nishi D, Yonemoto N, et al. Tachikawa project for prevention of posttraumatic stress disorder with polyunsaturated fatty acid (TPOP): study protocol for a randomized controlled trial[J]. BMC Psychiatry, 2013, 13: 8. DOI: 10.1186/1471-244X-13-8.
[1] 江钰璇, 陈颖, 周钟明, 温宝泓, 陈文韬, 钟国庆, 张余, 李丽萍. 全身关节过度活动的研究进展[J]. 中华关节外科杂志(电子版), 2023, 17(01): 52-59.
[2] 张永博, 张亮, 陈浏阳, 戴睿, 孙华, 杨盛, 孟博, 彭晴. 线粒体与椎间盘退变[J]. 中华损伤与修复杂志(电子版), 2023, 18(03): 265-269.
[3] 樊逸隽, 杨枫, 王玮, 殷鹤英, 刘俊. 喉前淋巴结转移对甲状腺乳头状癌诊疗价值的研究进展[J]. 中华普通外科学文献(电子版), 2023, 17(04): 306-310.
[4] 王金申, 朱华, 刘景磊, 石玉龙. 造口旁疝的诊治浅析[J]. 中华疝和腹壁外科杂志(电子版), 2022, 16(06): 624-627.
[5] 张林, 刘芳, 赵静, 刘勇, 周青. 远程康复在慢性阻塞性肺疾病患者肺康复中的研究进展[J]. 中华肺部疾病杂志(电子版), 2023, 16(04): 601-604.
[6] 李丹阳, 李满祥. 肠道菌群失调在肺动脉高压发病中的研究进展[J]. 中华肺部疾病杂志(电子版), 2023, 16(03): 432-434.
[7] 谯钰琪, 惠盼, 南岩东. DGKζ的结构功能及研究进展[J]. 中华肺部疾病杂志(电子版), 2023, 16(01): 117-120.
[8] 李青原, 冯同, 邱雪琴, 李万成. 迷迭香提取物防治肺纤维化研究进展[J]. 中华肺部疾病杂志(电子版), 2022, 15(06): 908-911.
[9] 王冠, 徐兴祥. 吸入药物在慢性阻塞性肺疾病和肺癌中的应用及进展[J]. 中华肺部疾病杂志(电子版), 2022, 15(06): 904-907.
[10] 秦富豪, 郑正, 江滨. 间充质干细胞在克罗恩病肛瘘治疗中的研究进展[J]. 中华细胞与干细胞杂志(电子版), 2023, 13(03): 172-177.
[11] 黄军杰, 王烈, 赵虎, 夏印, 张再重. lncRNA作为ceRNA参与婴幼儿血管瘤发生发展机制的研究进展[J]. 中华细胞与干细胞杂志(电子版), 2022, 12(06): 360-366.
[12] 蓝冰, 王怀明, 王辉, 马波. 局部晚期结肠癌膀胱浸润的研究进展[J]. 中华结直肠疾病电子杂志, 2023, 12(06): 505-511.
[13] 黄文鹏, 邱永康, 杨琦, 宋乐乐, 陈钊, 范岩, 康磊. PET相关影像组学在肿瘤预后中的研究进展[J]. 中华消化病与影像杂志(电子版), 2023, 13(02): 104-110.
[14] 吴一菡, 雷章, 卢宏达. MUC16/CA125在良恶性肿瘤诊治中的作用及其研究进展[J]. 中华临床医师杂志(电子版), 2023, 17(05): 591-595.
[15] 肖国中, 林宏城. 大便失禁治疗技术的研究进展[J]. 中华临床医师杂志(电子版), 2022, 16(07): 696-700.
阅读次数
全文


摘要